Ian Douglas
Impact in
- Geriatrics and Gerontology top 1%
- Toxicology top 0.5%
Papers in
- Toxicology 13
- Pharmacovigilance and Adverse Drug Reactions 13
-
- Advanced Causal Inference Techniques 13
- Statistical Methods in Clinical Trials 11
- Co-authors
- Liam SmeethKrishnan BhaskaranDavid A. LeonIsabel dos‐Santos‐SilvaStephen EvansHarriet ForbesHeather WhitakerIrene Petersen
- Journals
- Pharmacoepidemiology and Drug Safety (18 papers)BMJ Open (16 papers)British Journal of Clinical Pharmacology (11 papers)BMJ (10 papers)PLoS Medicine (8 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Ian Douglas
145 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Geriatrics and Gerontology 238
- Toxicology 203
- Physiology 1.3k
- Statistics and Probability 383
- Psychiatry and Mental health 698
Countries citing papers authored by Ian Douglas
This map shows the geographic impact of Ian Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Douglas more than expected).
Fields of papers citing papers by Ian Douglas
This network shows the impact of papers produced by Ian Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Douglas. The network helps show where Ian Douglas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian Douglas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 4 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 22 | |
| 12 | 2020 | 8 | |
| 13 | 2019 | 15 | |
| 14 | 2019 | 9 | |
| 15 | 2018 | 18 | |
| 16 | 2018 | 9 | |
| 17 | 2016 | 13 | |
| 18 | 2015 | 9 | |
| 19 | 2007 | 12 | |
| 20 | Tutorials: Things We Could Do Better. | 1985 | 1 |
About Ian Douglas
Ian Douglas is a scholar working on Toxicology, Statistics and Probability, Family Practice, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism, having authored 155 papers that have together received 7.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Advanced Causal Inference Techniques (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers), Diabetes Treatment and Management (12 papers), Statistical Methods in Clinical Trials (11 papers), Asthma and respiratory diseases (11 papers) and Atrial Fibrillation Management and Outcomes (9 papers). The work is most often cited by research in Geriatrics and Gerontology (238 citations), Toxicology (203 citations), Physiology (1.3k citations), Statistics and Probability (383 citations) and Psychiatry and Mental health (698 citations). Ian Douglas has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Liam Smeeth, Krishnan Bhaskaran, David A. Leon, Isabel dos‐Santos‐Silva, Stephen Evans, Harriet Forbes, Heather Whitaker, Irene Petersen, Stuart Pocock and Jennifer K Quint. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, BMJ Open, British Journal of Clinical Pharmacology, BMJ and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.